Non-Opioid Therapeutics And Significant Pain Treatments Make For A Buy Rating
September 02, 2015 at 10:58 AM EDT
The share price of Recro Pharma Inc(NASDAQ: REPH) has surged more than 356 percent year-to-date. Ching-Yi Lin of HC ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.